Michael Lyman is a Senior Research Scientist at Incyte, leveraging over two decades of experience in the pharmaceutical industry, with a strong focus on Drug Metabolism and Pharmacokinetics (DMPK). Previously, they held significant roles at Merck and Exelixis Inc., where they founded a DMPK lab, enhanced project management, and managed Phase II clinical studies. Their expertise includes executing complex study designs and fostering safety and compliance in research settings. Michael earned a Bachelor of Science in Biology from Delaware Valley University and a Master of Science in Molecular Biology from Lehigh University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices